First, we analyzed the expression of GLDC in 51 normal and 489 prostate cancer patients from the TCGA database, which showed that GLDC mRNA levels were obviously higher in prostate cancer samples than in normal prostate tissues (Figure 4A). This evidence concerns the gene GLDC and prostate cancer.